Pregnancy RSV vaccine effects on newborns, breastfeeding, and child health
Neonatal, Lactation, and Child Health Outcomes Following RSV Vaccination During Pregnancy
This project looks at whether getting the RSV vaccine during pregnancy affects newborn health, breastfeeding, growth, development, and allergic outcomes in early childhood.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Healthpartners Institute NIH-funded |
| Lab location | 1 site (Bloomington, UNITED STATES) |
| Project ID | NIH-11311951 on NIH RePORTER |
What this research studies
If you join, researchers will follow babies whose mothers got the prenatal RSVpreF vaccine and compare them with babies whose mothers did not get the vaccine. They will use medical records, brief surveys, and routine pediatric visit data to track newborn outcomes, breastfeeding experiences, growth, neurodevelopment, and allergic conditions over time. The team will pay special attention to preterm birth and early neonatal health because the original vaccine trial had limited data for people at high risk of early delivery. Participation may involve allowing access to your and your child’s health records and answering short questionnaires at intervals.
Who could benefit from this research
Good fit: Ideal participants are pregnant people who received (or plan to receive) the prenatal RSVpreF vaccine and their newborns and young children, particularly those receiving care at participating HealthPartners clinics.
Not a fit: People who are not pregnant, not planning pregnancy, or who did not receive the prenatal RSV vaccine are unlikely to gain direct benefit from participating.
Why it matters
Potential benefit: If successful, this research could provide clearer safety information to help parents and clinicians make informed decisions about RSV vaccination during pregnancy.
How similar studies have performed: A large clinical trial showed the vaccine cuts severe RSV illness in infants, but that trial excluded people at high risk for preterm birth and left unanswered questions about neonatal, lactation, and longer-term child outcomes.
Where this research is happening
Bloomington, UNITED STATES
- Healthpartners Institute — Bloomington, United States (Active)
Researchers
- Principal investigator: Palmsten, Kristin — Healthpartners Institute
- Study coordinator: Palmsten, Kristin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.